byiShook Opinion
Jan 15, 2025 - 11:35
There's still a lot to like about Eli Lilly stock, an analyst said Wednesday after the weight-loss drugs kingpin cut its sales view. The post Eli Lilly: What's Left To Like? A Lot, Says One Analyst. appeared first on Investor's Business Daily.
There's still a lot to like about Eli Lilly stock, an analyst said Wednesday after the weight-loss drugs kingpin cut its sales view.
The post Eli Lilly: What's Left To Like? A Lot, Says One Analyst. appeared first on Investor's Business Daily.